CPH 0.00% 0.9¢ creso pharma limited

It's about the cash burn rate and the new revenue streams. If a...

  1. 3,923 Posts.
    lightbulb Created with Sketch. 762
    It's about the cash burn rate and the new revenue streams. If a substantial revenue stream eventuates, probably the market will sit up and take notice. If not............

    The anibidiol launch looks to be slightly delayed- this is where the first substantial revenue stream looks set to come from. An announcement on this would ignite the engines, one would think.

    People are waking up to the benefits of MC. Big future.

    -------------------------------------------------------------------------------------------------------------
    This post is based on my own research and is not investment advice. When making investment decisions, always DYOR.
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.